The 35th Panhellenic Hematology Congress in Thessaloniki, running from November 7 to 9, gathers over 1,200 hematologists to discuss the latest developments in hematological diseases. According to Elisavet Grouzi, president of the Hellenic Hematology Society, important announcements are expected. Key presentations will focus on gene therapies, targeted treatments, and innovative medications that have transformed hematological cancers into manageable chronic conditions, enabling patients to enjoy a better quality of life without significant issues.